ICU Medical, Inc. ICUI
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.05% | -1.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.05% | -1.94% | |||
| Cost of Revenue | 3.56% | -4.06% | |||
| Gross Profit | 4.81% | 1.60% | |||
| SG&A Expenses | -1.71% | -0.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.06% | -2.87% | |||
| Operating Income | 36.70% | 16.46% | |||
| Income Before Tax | 670.86% | 75.08% | |||
| Income Tax Expenses | 120.37% | -1,208.48% | |||
| Earnings from Continuing Operations | -36.66% | 291.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -36.66% | 291.51% | |||
| EBIT | 36.70% | 16.46% | |||
| EBITDA | 13.35% | 4.54% | |||
| EPS Basic | -37.25% | 290.93% | |||
| Normalized Basic EPS | 133.55% | 159.40% | |||
| EPS Diluted | -36.67% | 288.29% | |||
| Normalized Diluted EPS | 137.08% | 155.07% | |||
| Average Basic Shares Outstanding | 0.95% | 0.31% | |||
| Average Diluted Shares Outstanding | -0.55% | 2.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||